GlaxoSmithKline plc Acquires Sirtris Pharmaceuticals for $720,000,000

  • Feed Type
  • Date
    4/22/2008
  • Company Name
    Sirtris Pharmaceuticals
  • Mailing Address
    200 Technology Square Cambridge, MA 02139
  • Company Description
    Sirtris Pharmaceuticals” is a biopharmaceutical company developing and commercializing novel therapeutics that modulate sirtuins, a recently discovered family of enzymes that promotes the body’s natural defense against disease. Also known as class III histone deacetylases (HDACs), sirtuins are attractive drug targets for diseases of aging, including metabolic and neurological diseases.
  • Website
    http://www.sirtrispharma.com/
  • Transaction Type
    M&A
  • Transaction Amount
    $720,000,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    The acquisition will be paid for with all cash.

Trending on Xconomy